Moreover, NCTD-induced cell death was comparable to that of the anti-cancer drug gefitinib, a tyrosine kinase inhibitor for EGFR, based on the immunoblot analysis of the expressed proteins after the treatment of NCTD. The gene discussed is EGFR; the disease is cancer.